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While human T-cell leukemia virus type 1 (HTLV-1) is associated with the development of adult T-cell leukemia (ATL), HTLV-2 has not
been reported to be associated with such malignant leukemias. HTLV-1 Tax1 oncoprotein transforms a rat fibroblast cell line (Rat-1) to form
multiple large colonies in soft agar, and this activity is much greater than that of HTLV-2 Tax2. We have demonstrated here that the increased
number of transformed colonies induced by Tax1 relative to Tax2 was mediated by a PDZ domain-binding motif (PBM) in Tax1, which is
absent in Tax2. Tax1 PBM mediated the interaction of Tax1 with the discs large (Dlg) tumor suppressor containing PDZ domains, and the
interaction correlated well with the transforming activities of Tax1 and the mutants. Through this interaction, Tax1 altered the subcellular
localization of Dlg from the detergent-soluble to the detergent-insoluble fraction in a fibroblast cell line as well as in HTLV-1-infected T-cell
lines. These results suggest that the interaction of Tax1 with PDZ domain protein(s) is critically involved in the transforming activity of Tax1,
the activity of which may be a crucial factor in malignant transformation of HTLV-1-infected cells in vivo.
D 2003 Elsevier Inc. All rights reserved.Keywords: HTLV-1; Tax; PDZ; Dlg; Adult T-cell leukemiaIntroduction
Adult T-cell leukemia (ATL) is an extremely aggressive
human CD4+ T-cell leukemia (Sugamura and Hinuma,
1993; Uchiyama et al., 1977). For instance, ATL is resistant
to chemotherapy and most patients die within 1 year of
diagnosis. Human T-cell leukemia virus type 1 (HTLV-1)
infection of CD4 T cells is the first step in ATL develop-
ment, but by itself this is not sufficient for leukemia
development because a minority of HTLV-1 infected sub-
jects (approximately 5%) develop ATL on average 60–70
years after the infection (Hinuma et al., 1981; Poiesz et al.,
1980; Sugamura and Hinuma, 1993).0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.10.006
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E-mail address: fujiimas@med.niigata-u.ac.jp (M. Fujii).HTLV type 2 (HTLV-2) was originally isolated from a
cell line established from a T-cell variant of hairy cell
leukemia (Chen et al., 1983a). HTLV-1 and HTLV-2 can
transform primary human T cells in both an interleukin (IL)-
2-dependent and -independent manner in vitro, with equiv-
alent efficiency (Chen et al., 1983b; Miyoshi et al., 1981;
Yamamoto et al., 1982). However, HTLV-2 is not associated
with ATL or leukemias of such a malignant nature (Suga-
mura and Hinuma, 1993). Thus, elucidation of the mecha-
nisms by which these two viruses determine distinct
outcomes will provide fundamental insights into the initia-
tion of multi-step leukemogenesis.
HTLV-1 and HTLV-2 encode Tax1 and Tax2 protein,
respectively, and these two proteins exhibit more than 70%
amino acid identity (Seiki et al., 1986; Slamon et al., 1984).
They are crucial for the transforming activity of HTLV-1
and HTLV-2. For instance, Tax1 by itself immortalizes
primary human T cells in an IL-2-dependent manner (Akagi
and Shimotohno, 1993; Grassmann et al., 1992). Recombi-
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tax2 gene, respectively, cannot transform primary human T
cells (Robek and Ratner, 1999; Ross et al., 1996).
Tax1 is a multifunctional protein (Yoshida, 2001). It
activates the transcription of many cellular genes associated
with cell growth, such as genes encoding cytokines (Inoue
et al., 1986; Seikevitz et al., 1987), cytokine receptors
(Ballard et al., 1988; Cross et al., 1987; Inoue et al.,
1986; Maruyama et al., 1987), an anti-apoptotic protein
(Tsukahara et al., 1999), cell cycle regulators (Akagi et al.,
1996; Iwanaga et al., 2001; Mori et al., 2002; Santiago et al.,
1999), and protooncogenes (Fujii et al., 1991; Yoshida,
2001). Moreover, Tax1 inactivates several negative cell-
growth regulators such as p53, p16INK, and MAD1 (Akagi
et al., 1997; Jin et al., 1998; Pise-Masison et al., 1998;
Suzuki et al., 1996). The comparative studies of Tax1 and
Tax2 have not, however, elucidated the underlying mecha-
nism for the different pathogenic properties between HTLV-
1 and HTLV-2.
Recent results have provided an attractive clue for the
different pathogenic properties of these two viruses. Tax1
and Tax2 induce transformed colonies in soft agar (colony
formation in soft agar, or CFSA) in a rat fibroblast cell line
(Rat-1), and the activity of Tax2 is lower than that of Tax1
(Endo et al., 2002). Their chimeric proteins indicate that the
C-terminal 53 amino acids of Tax1 are responsible for the
high CFSA activity relative to Tax2. This C-terminal Tax1
fragment, but not the Tax2 counterpart, contains a PDZ
domain-binding motif (PBM), C-terminal S/TXV (S/T,
serine or threonine; X, any amino acid; V, valine), and it
binds to PDZ domain-containing protein discs large (Dlg), a
mammalian homologue of Drosophila discs large tumor
suppressor (Kiyono et al., 1997; Lee et al., 1997; Rousset et
al., 1998; Suzuki et al., 1999). Thus, PDZ domain-contain-
ing protein(s), including Dlg, are candidates for mediating
the high CFSA activity of Tax1, and thereby the leukemo-
genic properties of HTLV-1.
In this study, we demonstrate that the Tax1 PBM is
indeed involved in the increased CFSA activity of Tax1
relative to Tax2. Tax1, through PBM, interacted with Dlg,
whereas Tax2 minimally did so, and moreover, the interac-
tion between Tax1 and Tax2 mutants correlated well with
their CFSA activities. We will discuss these findings in the
context of the transformation of Rat-1 cells by Tax1 as well
as malignant transformation of HTLV-1-infected T cells.Fig. 1. Structure of Tax1, Tax2B, and their mutant proteins. The amino acid
sequence of PBM and its mutants are indicated.Results
PDZ domain-binding motif in Tax1 is responsible for the
high transforming activity
We previously reported that the C-terminal 53 amino
acids of Tax1 were responsible for the high transforming
activity relative to Tax2, and that this fragment contains a
PDZ domain-binding motif (PBM) (Endo et al., 2002). Toexamine the involvement of the Tax1 PBM in Tax1 trans-
forming activity, we constructed two types of mutant genes.
The TaxDC gene contains a C-terminal four-amino acid
deletion in Tax1, thereby removing the PBM motif (T/SXV)
(Fig. 1). The Tax2B +C gene has an additional 10 Tax1
amino acids containing PBM at the C-terminus of Tax2B. In
addition, we constructed two substitution mutants of Tax1
PBM, at amino acids 351 and 353, in the context of Tax1
and Tax2B +C. These constructs were introduced into a
mammalian expression vector (pHhPr-1-neo) carrying the
neomycin resistance gene, and the plasmids were trans-
fected into Rat-1 cells, and the cells were selected by
neomycin (G418). Anti-Tax1 monoclonal antibody showed
that all these transfectants expressed the Tax1 protein or the
mutant one. The amount of Tax1 protein in Rat-1 cells was
higher than those of the mutants in five (including No2 and
No3 in Fig. 2A) out of seven experiments. On the other
hand, the amount of Tax2B +C protein in Rat-1 cells,
detected by an anti-Tax2B antibody, was higher than that
of Tax2B, Tax2B351A, and Tax2B353A in six (including
No6, No7, No8 in Fig. 2B) out of seven experiments. Anti-
a-Tubulin antibody indicated that the equivalent amount of
the proteins was loaded on the respective lane in the
Western blot analysis (Fig. 3). These results suggested that
Tax1 PBM increase expression of Tax1 protein in Rat-1
cells. Then, these transfectants were seeded into soft agar to
measure the transforming activity (colony formation in soft
agar, or CFSA). The Rat-1/Tax1 cells formed multiple large
colonies in soft agar relative to the control cells [see Mean
(%) in Fig. 2A]. The Rat-1/TaxDC cells also formed more
colonies relative to the control, but the number of the
colonies was reproducibly lower than for Rat-1/Tax1. In
addition, the mutation of PBM at amino acids 351 and 353
in Tax1 also reduced the numbers of colonies. The increased
transforming activity of Tax1 relative to those of the mutants
is not singly due to the increased expression because Tax1
was expressed equivalently or less than TaxDC or Tax353A
in Rat-1 cells in some experiments (TaxDC in No1,
Tax353A in No2, TaxDC in No4). Tax2B and Tax2B +C
also transformed Rat-1 cells to form positive colonies
relative to the control, and the number of the colonies
induced by Rat-1/Tax2B +C cells was more than that of
Rat-1/Tax2B. In addition, the mutation of PBM at amino
acids 351 and 353 in Tax2B +C also reduced the numbers
of colonies. The almost equivalent expression of Tax2B and
Tax2B +C in the experiment No5 suggested that the in-
creased expression of Tax2B +C was not the only reason for
Fig. 2. The PDZ domain-binding motif (PBM) of Tax1 is responsible for the increased number of Rat-1 transformed colonies. (A, B) The cell lysate was
prepared from Rat-1 cells stably transfected with the indicated plasmids, and the amount of Tax in each cell lysate was measured by Western blot analysis using
an anti-Tax1 antibody (A) or anti-Tax2B antibody (B). The Rat-1 cells transfected with pHhPr-1-neo plasmid used as a control are indicated as hA. These Rat-
1 cells, in which expression of the respective Tax proteins was measured by Western blot analysis, were seeded in soft agar. Three weeks after the inoculation,
the number (%) of colonies was determined by light microscopy. The CFSA assay of No1 through No8 was performed in duplicate, and the mean (%) indicate
the averages and standard deviations of the activity of the indicated Rat-1 transfectants above. ND: not determined.
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together, these results indicate that the Tax1 PBM increases
the number of the transformed colonies in soft agar, and that
amino acids 351 and 353 in Tax1 PBM are critical for the
activity.
Tax1 binds to Dlg through PBM
The human Dlg protein is a well-known PDZ domain-
containing protein, and it was isolated as a mammalianFig. 3. The expression of Tax and mutant proteins in Rat-1 cells. The cell lysate w
and the amount of Tax and a-Tubulin in each cell lysate was measured by Wester
Tubulin antibody.homologue of Drosophila discs large tumor suppressor. Dlg
interacts with Tax1 through its PBM (Rousset et al., 1998;
Suzuki et al., 1999). To examine the involvement of Dlg in
the transformation by Tax1, the tax1 and tax2B plasmids
and their respective mutant plasmids were transiently trans-
fected into a human embryonic kidney cell line (293T)
together with the Dlg expression plasmid. Dlg protein in
the lysates prepared from 293T cells was immunoprecipi-
tated with anti-Dlg antibody, and then the amount of Tax1 in
the precipitates was analyzed by Western blot. Tax1 wasas prepared from Rat-1 cells stably transfected with the indicated plasmids,
n blot analysis using an anti-Tax1 antibody, anti-Tax2B antibody or anti-a-
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as TaxDC was minimally detected in the complex (Fig. 4A).
Tax351A and Tax353A were also detected in the Dlg
complex, but the amounts were much lower than that of
Tax1. The reduced detection of TaxDC, Ta351A, and
Tax353A in the complex was not due to their reduced
expression in 293T cells because anti-Tax1 antibody
detected the equivalent expression of these mutant proteins
to that of Tax1 in 293T cells (Fig. 4C). In addition, anti-Dlg
immunoprecipitated the equivalent amount of Dlg protein
from the 293T cells transfected with these tax1 plasmids
(Fig. 4B). Unlike Tax1, Dlg minimally precipitated Tax2B,
whereas it efficiently precipitated Tax2B +C. The Dlg
complex also contained Tax2B351A and Tax2B353A, and
the amount was much higher than that of Tax2B but still
lower than that of Tax2B +C. These results showed that
Tax1, but not Tax2B, binds to Dlg, and the interaction
correlated with the number of colonies induced by the
respective Tax protein in Rat-1 cells (Fig. 2).
Tax1 alters the subcellular localization of Dlg
Having demonstrated that Dlg can interact with Tax1 in
293T cells, we next examined the subcellular localization of
endogenous Dlg in the absence and presence of Tax1. In the
absence of Tax1, co-staining by anti-Dlg (red), anti-Tax1
(green), and Hoechst 33342 (nucleus; blue) showed that
endogenous Dlg was mainly localized in the cytoplasm (Fig.
5). In the presence of Tax1, Dlg colocalized with Tax1, and
the complex (yellow) was detected mainly in the cytoplasm.
In contrast, TaxDC, which cannot interact with Dlg, did notFig. 4. Tax1 interacts with Dlg through the PBM. (A, B) Cell lysate was prepared
indicated tax plasmid or pHhPr-1-neo (hA). Each cell lysate was immunoprecipita
were analyzed by Western blot (WB) using an anti-Tax1 antibody (left), anti-Tax2
indicated. (C) Cell lysate prepared from 293T cells transfected as described abo
immunoprecipitation.obviously show the colocalization with Dlg. Exogenous Dlg
protein fused with green fluorescent protein (GFP-Dlg) in
the absence of Tax1 was also detected mainly in the
cytoplasm, and again the localization was altered by Tax1
but not TaxDC into the Tax1-containing complex (Fig. 6).
These results indicated that Tax1 aberrantly sequesters Dlg
within the Tax1-containing complex.
Tax1 translocates Dlg from the detergent-soluble fraction
into the insoluble fraction in 293T cells and
HTLV-1-infected T-cell lines
We further delineated subcellular localization of Dlg and
Tax1 by cell fractionation. The 293T cells transiently trans-
fected with Tax1 expression plasmid were lysed by mild
detergent (1% NP40) or by SDS sample buffer, and the
amount of endogenous Dlg and Tax1 in the soluble fraction
by NP40, the insoluble fraction and the total fraction lysed
directly by SDS-sample buffer, was measured by Western
blotting. Dlg in 293T cells transfected with the control
plasmid (hA) was detected both in the NP40-soluble and
NP40-insoluble fraction (hA in Fig. 7A). However, Dlg in
the soluble faction became undetectable in response to Tax1
expression while that in the insoluble faction was increased.
Since the amount of total Dlg proteins prepared by SDS
sample buffer in 293T cells was minimally affected by Tax1,
these results indicated that Tax1 translocates the Dlg protein
from the detergent-soluble to the detergent-insoluble frac-
tion in 293T cells. It should be mentioned that the detergent-
soluble Dlg in the presence of Tax1 was detected in Fig. 4
but not in Fig. 7A. This is likely to be due to the differentfrom 293T cells transfected with the human Dlg plasmid together with the
ted (IP) with anti-Dlg antibody, and the proteins in the immunoprecipitates
B antibody (right), or anti-Dlg (B). The antibodies used for IP and WB are
ve was also analyzed by an anti-Tax1 (left) or anti-Tax2B (right) without
Fig. 6. GFP-Dlg colocalizes with Tax1 in 293T cells. The 293T cells were transfected with the GFP-Dlg plasmid together with the tax1, taxDC, or pHhPr-1-neo
plasmid (hA). At 48 h after transfection, the cells were incubated with mouse anti-Tax1 antibody. After washing, the cells were further incubated with TRITC-
labeled anti-mouse IgG. After washing, the cells were stained with Hoechst 33258 for nuclear staining. The cells were then examined for the staining for anti-
Tax1 (red), GFP-Dlg (green), and Hoechst (blue) by fluorescent light microscopy (magnification,400).
Fig. 5. Subcellular colocalization of endogenous Dlg and Tax1. The 293T cells were transfected with the tax1, taxDC, or pHhPr-1-neo (hA) plasmid. Then, the
cells were stained with anti-Dlg (red), anti-Tax1 (green), and with Hoechst 33258 (blue) for nuclear staining. The stained cells were examined by fluorescent
light microscopy (magnification,400).
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Fig. 8. The expression of detergent-soluble Dlg in HTLV-2-infected T-cell
line. The indicated human T-cell lines were divided into two groups. One
group was treated with the lysis buffer A. After centrifugation, the
supernatant was used as the soluble fraction, and the resultant pellet was
further treated with SDS sample buffer and used as the insoluble fraction.
The other group was directly treated with SDS sample buffer and used as
the total fraction. Three types of samples were size-fractionated by SDS-
PAGE, and the amount of Dlg proteins was measured by Western blot using
an anti-Dlg antibody. HTLV-1 or HTLV-2 infection in the T-cell lines is
indicated.
Fig. 7. Tax1 alters subcellular localization of Dlg. (A, B) 293T cells transfected with the indicated tax plasmids or pHhPr-1-neo plasmid (hA) (A), or the
indicated human T-cell lines (B) were divided into two groups. One group was treated with the lysis buffer A. After centrifugation, the supernatant was used as
the soluble fraction, and the resultant pellet was further treated with SDS sample buffer and used as the insoluble fraction. The other group was directly treated
with SDS sample buffer and used as the total fraction. Three types of samples were size-fractionated by SDS-PAGE, and the amount of Tax and Dlg proteins
was measured by Western blot using anti-Tax1 antibody, anti-Tax2B antibody, or anti-Dlg antibody. HTLV-1 infection in the T-cell lines is indicated.
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experiments, such that much more lysate was used in Fig.
4 than in Fig. 7A. The translocation of Dlg by Tax1 was
dependent on functional PBM because TaxDC, Tax351A, or
Tax353A did not induce subcellular translocation of Dlg
protein. Tax2B +C but not Tax2B also translocated Dlg
protein from the detergent-soluble to the insoluble fraction.
The translocation of Dlg protein by Tax2B +C was again
dependent on functional PBM because Tax2B351A and
Tax2B353A that bind less efficiently to Dlg than Tax2B +C
did not induce translocation of Dlg. These results showed
that Tax1 but not Tax2B, through the interaction with Dlg,
alters the subcellular localization of Dlg from the detergent-
soluble to the insoluble fraction in 293T cells.
We next examined whether Tax1 alters the subcellular
localization of Dlg in HTLV-1-infected T-cell lines (Fig.
7B). In three HTLV-1-uninfected cell lines, Dlg was
detected in the detergent-soluble fraction, although it was
undetectable in two HTLV-1-infected cell lines (HUT102,
SLB-1). On the other hand, detergent-insoluble Dlg was
more abundant in the HTLV-1-infected cell lines than
HTLV-1-uninfected cell lines. These results suggested that
Tax1 alters the subcellular localization of Dlg from the
detergent-soluble to the detergent-insoluble fraction in
HTLV-1-infected T-cell lines. In addition, we noticed that
the amount of total Dlg protein solubilized by SDS-sample
buffer in two HTLV-1-infected cell lines was lower than that
in HTLV-1-uninfected cell lines. Thus, Tax1 may reduce the
total quantity of Dlg protein in HTLV-1-infected T-cell lines.Unlike HTLV-1-infected T-cell lines, the amount of deter-
gent-soluble and total Dlg in HTLV-2-infected T cells was
equivalent to those of HTLV-1-uninfeced ones, although the
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undetectable (Fig. 8). These results suggested that the
quantitative and qualitative alteration of Dlg is specific to
HTLV-1-infected T-cell lines, and such alteration is mini-
mum in HTLV-2-infected ones. In addition, we consistently
observed that the molecular weight of Dlg in HTLV-1-
infected cell lines was larger than that in HTLV-1-uninfected
ones. Thus, the interaction of Dlg with Tax1 may induce the
post-transcriptional modification of Dlg protein such as
phosphorylation.Discussion
Once infected, HTLV-1 and HTLV-2 achieve life-long
persistent infection in human T cells in vivo (Sugamura and
Hinuma, 1993). However, only some HTLV-1-infected
individuals, but not HTLV-2 ones, develop an aggressive
form of leukemia 60–70 years after the infection. Since
HTLV-1 and HTLV-2 equivalently transform T cells in vitro,
HTLV-1 but not HTLV-2 presumably encode an activity to
initiate leukemogenesis that is distinct from in vitro trans-
formation of T cells. Thus, these two viruses should provide
fundamental insights into the initiation of multi-step leuke-
mogenesis. We recently showed that HTLV-1 Tax1 exhibits
higher transforming (CFSA) activity in a fibroblast cell line
(Rat-1) than Tax2 (Endo et al., 2002). Here, we extended
these observations and showed that a PBM at the C-terminal
end of Tax1 is a factor responsible for the increased CFSA
activity relative to Tax2 (Fig. 2). Thus, our results suggest
that the Tax1 PBM could be a factor for initiating the first
step of leukemogenesis by HTLV-1.
Tax1, through the PBM, interacted with Dlg, the human
homologue of Drosophila tumor suppressor containing PDZ
domains, and moreover the interaction correlated well with
the high CFSA activity of Tax1. These results suggested that
Dlg is involved in the high CFSA activity of Tax1. It should
be, however, noted that several PDZ domain proteins have
been shown to interact with Tax1 (Rousset et al., 1998).
Thus, PDZ domain-containing protein(s) other than Dlg or
more than one PDZ domain protein may augment the CFSA
activity of Tax1.
The present results suggested that the Tax1 PBM has the
activity to augment the expression of Tax1 proteins in Rat-1
cells (Fig. 2). The enhancement of Tax1 protein expression
by the PBM was observed in stable Rat-1 transfectants,
whereas such enhancement was not apparent after transient
overexpression of Tax1 in 293T cells (data not shown).
Thus, the interaction of Tax1 with the limiting amount of
PDZ domain-containing protein(s) in Rat-1 cells may me-
diate the increased protein expression.
Through the interaction, Tax1 altered subcellular locali-
zation of Dlg from the detergent-soluble to the detergent-
insoluble fraction (Fig. 7). Since Tax1 is detected in both the
detergent-soluble and the detergent-insoluble fraction, the
Tax1 complex with Dlg is likely to move preferentially intothe detergent-insoluble fraction. This aberrant sequestration
of Dlg within the cells correlated well with the high CFSA
activity of Tax1. Exogenous expression of Dlg in a mouse
fibroblast cell line, NIH3T3, inhibits the cell cycle progres-
sion from GO/G1 to S phase (Ishidate et al., 2000), and Tax
can release the cell cycle arrest (Suzuki et al., 1999). Thus,
the present results suggest that aberrant sequestration of Dlg
within the insoluble fraction by Tax1 is involved in the
inactivation of Dlg function towards the cell cycle, as well
as the increased CFSA activity.
Tax1 was detected both in the detergent-soluble and the
insoluble fraction (Fig. 7). Trihn et al. (1997) showed that
Tax1 interacts with a class of intermediate filaments, the
cytokeratins (Ker), and discussed that the interaction of
Tax1 with the cytokeratins may be involved in the morpho-
logic changes observed in Tax1-expressing cells. Thus, the
detergent-insoluble Tax1 may represent the protein interact-
ing with cytoskeleton component(s), and may be responsi-
ble for the selective function(s) of Tax1.
The molecular weight of Dlg in HTLV-1-infected cell
lines was larger than those in HTLV-1-uninfected ones (Fig.
7B). By using immunoprecipitation analysis, Suzuki et al.
(1999) also showed that the Dlg complex with Tax1
migrated slower than Dlg in the absence of Tax1, and this
slow migration of Dlg induced by Tax1 was canceled by
treating the complex with bacterial alkaline phosphatase.
These results indicated that Tax1 induces the phosphoryla-
tion of Dlg. Since Tax1 by itself has no kinase activity, Tax1
might activate putative Dlg kinase(s). In normal cells,
phosphorylation of Dlg was mainly detected in G2/M phase
(Suzuki et al., 1999). Thus, the characterization of phos-
phorylated Dlg and the significance in cell cycle regulation
would elucidate the mechanism of Dlg regulation in normal
cells as well as HTLV-1-infected ones.
Several viral oncoproteins such as adenovirus 9 E4ORFl
and the human papilloma virus (HPV) E6 contain a PBM.
Interestingly, only E6 proteins that are derived from high-
risk HPVs but not low-risk ones have a functional PBM, and
interact with PDZ domain proteins such as Dlg (Kiyono et
al., 1997; Lee et al., 1997). Furthermore, E6 and E4ORFl
mutants that lose the ability to interact with Dlg can no
longer transform fibroblast cell lines (Kiyono et al., 1997;
Weiss et al., 1997). In addition, E6 induces the degradation
of Dlg by an ubiquitin-mediated proteasome mechanism
(Gardiol et al., 1999). Thus, the inactivation of PDZ domain
proteins is likely to be a common target for high-risk
oncoviruses to induce the malignant transformation of the
virus-infected cells.
There are two types of simian T-cell leukemia virus
(STLV), STLV-1 and STLV-2. Interestingly, only STLV-1
is associated with the development of leukemia or lympho-
ma, although there are only few reports of the incidence
(Hubbard et al., 1993; Voevodin et al., 1996). STLV-1 and
STLV-2 also express Tax1 and Tax2, respectively, and these
STLV Tax proteins have more than 70% amino acid identity
to HTLV Tax1, and only STLV Tax1 but not STLV-2 Tax2
Fig. 9. Comparison of C-terminal peptides of the indicated Tax proteins.
The amino acids of Tax2B, Tax2A, Tax2D, STLV-1 Tax1, and STLV-2
Tax2 that are identical to those of Tax1 are indicated by dashes. The
sequence accession number is J02029 for HTLV-1(ATK1), M10060 for
HTLV-2a, AF139382 for HTLV-2b, Y14365 for HTLV-2d, NC 000858 for
STLV-1, and NC 111815 for STLV-2.
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1995). Taken together, our results suggest that the PBM is
an evolutionally conserved factor responsible for the leuke-
mogenic properties of STLV-1 and HTLV-1.Materials and methods
Cell culture
Rat-1 and 293T cells are a rat fibroblast cell line and a
human embryonic kidney cell line, respectively. These cell
lines were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 4 mM L-glutamine, penicillin (50 U/
ml), and streptomycin (50 Ag/ml) at 37 jC in a humidified
5% CO2 atmosphere. Human T-cell lines used in the present
experiments have been characterized previously (Mori et al.,
1999; Sugamura et al., 1984). Jurkat, HUT78, and MOLT-4
are HTLV-1-negative T-cell lines. HUT102 and SLB-1 are
HTLV-1-positive human T-cell lines, although Ton-1 is an
HTLV-2-positive one. These T-cell lines were cultured in
RPMI1640 supplemented with 10% FBS, 4 mM L-gluta-
mine, penicillin (50 U/ml), and streptomycin (50 Ag/ml).
Plasmids
The tax1, tax2B, and their corresponding mutant genes
were cloned into the plasmid pHhPr-1-neo that has a h-
actin promoter for protein expression in mammalian cells
and neomycin-resistance gene as a selection marker (Mat-
sumoto et al., 1997). The Tax2B plasmid (pCAGGS-
Tax2B) was kindly provided by Dr. William W. Hall at
University College Dublin, Ireland (Lewis et al., 2000).
The mutant tax1 and tax2B genes were constructed by
the polymerase chain reaction method. The template to
construct mutant tax1 and tax2B cDNA was pBluescript-
tax1 and pCAGGS-Tax2B, respectively. The 3V primers
u s e d w e r e 5 V- GAAAAACATTTCCGATGAG -
GATCCCCCGCA-3V for taxDC, 5V-GAGGATCCTCA-
GACTTCGGCTTCGCGGAAATG-3 V for tax351A ,
5V-GAGGATCCTCAGGCTTCTGTTTCGCG-3Vfor tax353A,
5 V- TTGGATCCGAATTCAGACTTCTGTTTCT-
CGGAAATGTTTTTCACTCTTGGGATTGTTTGTGTGA-GACGG-3V for tax2B + C, 5V-TTGGATCCGAATTCAG-
ACTTCGGCTTCTCGGAAATGTTTTTCACTCTTGGG-
ATTGTTTGTGTGAGACGG-3V for tax2B351A, and
5VTTGGATCCGAATTCAGGCTTCTGTTTCTCGGAAAT-
GTTTTTCACTCTTGGGATTGTTTGTGTGAGACGG-3V
for tax2B353A, respectively. The common 5V primers for
tax1 and tax2B were 5V-AACAGCTATGACCATG-3V in the
pBluescript-tax1 plasmid and 5V-AAGGATCCGGCT-
TAAGCTTGCCACC-3V in pCAGGS-Tax2B, respectively.
DNA sequencing confirmed these mutant plasmids. Plas-
mid pcDNA3.1 pcDNA+-mycDlg (Dlg) is the expression
plasmid for human Dlg (Kohu et al., 2002).
Colony formation in soft agar (CFSA) assay
A linearized tax plasmid was transfected into Rat-1 cells
by the electroporation method using a Gene Pulser (Bio-Rad
Laboratories, Hercules, CA) at 200 V and 975 AF. The cells
were then cultured for more than 2 weeks in a selection
medium containing 500 Ag/ml of G418. Pools of resistant
cells (1104 cells) were seeded in 0.33% agarose contain-
ing 10% FBS/DMEM overlaid on 0.5% agarose in 60 mm
plates. After culturing for 3 weeks, the number of colonies
was examined under a light microscope, and colony number
(%) was calculated as the proportion of colonies measuring
more than 100 Am in diameter relative to colonies smaller
than 100 Am.
Western blotting
Rat-1 cells expressing Tax1 protein were lysed with
RIPA buffer [50 mM Tris (pH 8.0), 150 mM NaCl, 1.0%
Nonidet P-40(NP40), 0.5% deoxycholate, 0.1% sodium
dodecyl sulfate (SDS), 2.0 mM phenylmethanesulfonyl
fluoride, 20 Ag/ml aprotinin, 1.0 mM Na3VO4, and 1.0
mM NaF] for 30 min at 4 jC. After centrifugation, the cell
1ysate (25 Ag) was size-separated by electrophoresis under
reducing conditions in a 10% polyacrylamide gel with SDS
(SDS-PAGE), and the proteins in the gel were electronically
transferred onto a polyvinylidene difluoride membrane. The
membrane was incubated with Block Ace (Dainippon
Seiyaku, Osaka, Japan) for 1 h at room temperature to
inhibit nonspecific binding, and further incubated with
mouse anti-Tax1 antibody or rabbit anti-Tax2B antibody.
After washing with TBS-T [10 mM Tris–HCl (pH 8.0), 150
mM NaCl, and 0.05% Tween 20], the membranes were
further incubated with either anti-mouse or anti-rabbit
immunoglobulins conjugated with horseradish peroxidase
(Bio-Rad Technologies, Richmond, CA). Proteins recog-
nized by the antibodies in the membrane were visualized
using the ECL Western blotting detection system (Amer-
sham Biosciences, Piscataway, NJ). Antibodies used were
mouse anti-Tax1 monoclonal antibody (TAXY-7) (Tanaka et
al., 1991), rabbit anti-Tax2B polyclonal antibody (Lewis et
al., 2000), mouse anti-Dlg monoclonal antibody (BD Bio-
sciences Pharmingen, San Diego, CA), and mouse mono-
A. Hirata et al. / Virology 318 (2004) 327–336 335clonal anti-a-Tubulin antibody (Oncogene Research Prod-
ucts, San Diego, CA).
Co-immunoprecipitation assay
The tax plasmids were transiently transfected into 293T
cells together with the Dlg expression plasmid by the
lipofection method (Fugene6, Roche Molecular Systems,
Peasanton, CA). At 48 h after the transfection, the cells
were treated with lysis buffer A [25 mM Tris (pH 7.2), 150
mM NaCl, 1.0 mM EDTA, 1% NP40, 2.0 mM phenyl-
methanesulfonyl fluoride, 20 Ag/ml aprotinin, 1.0 mM
Na3VO4, 1.0 mM NaF], and the cell 1ysate was immuno-
precipitated with anti-Dlg antibody. The amount of Tax1,
Tax2B, and Dlg protein in the precipitates was analyzed by
Western blotting using anti-Tax1, anti-Tax2B, and anti-Dlg
antibody, respectively.
Immunofluorescence analysis
To analyze the localization of Tax1, TaxDC, and Dlg
proteins in 293T cells, the cells were cultured on 8-well
culture slides (Becton Dickinson Labware, Bedford, MA)
overnight. The 293T cells on the slides were then tran-
siently transfected with the tax plasmids or the GFP-Dlg
plasmid by the lipofection method (Fugene6). At 48 h after
transfection, they were fixed with 2% paraformaldehyde in
0.1 M phosphate-buffered saline (PBS) for 2 h at 4 jC.
The fixed cells were incubated with serum from a HTLV-1
carrier and a mouse anti-Dlg antibody (BD Biosciences
Pharmingen) or mouse anti-Tax1 antibody (TAXY-7).
After washing, the cells were further incubated with
tetramethylrhodamine-isothiocyanate (TRITC)-labeled an-
ti-mouse IgG (Beckman Coulter, Fullerton, CA) and fluo-
rescein isothiocyanate (FITC)-labeled anti-human IgG
(Beckman Coulter). After washing, the cells were further
stained with Hoechst 33258. The stained cells were
examined under an inverted microscope (Axiovert200)
equipped for epifluorescence (Carl Zeiss, Oberkochen,
Germany).
Cell fractionation assay
The 293T cells were transfected with the tax1, tax2B,
and mutant plasmids together with the Dlg plasmid by a
lipofection method (Fugene6). At 48 h after transfection,
the cells were divided into two groups. One was treated
with the lysis buffer A at 4 jC for 15 min. After
centrifugation, the supernatant was collected and used as
the soluble fraction, and the resultant pellet was further
treated with SDS sample buffer [125 mM Tris–HCl (pH
6.8), 2% SDS, 20% glycerol, 0.01% bromophenol blue,
and 10% h-mercaptoethanol] 4 jC for 15 min. The lysates
were used as the insoluble fraction. The other group was
directly treated with SDS sample buffer and used as the
total fraction. The three samples were size-fractionated bySDS-PAGE, and the amount of Tax and Dlg was measured
by Western blot.Acknowledgments
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